Skip to content

Medical-device intelligence

GNM: Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6

FDA product code GNM: Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GNM
FDA device name
Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6
Device class
1
Regulation number
866.3145
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

9 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Sep 8, 1995 to Sep 8, 1995.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GNM · Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-690

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
ENTEROVIRUS MONOCL ANTIBODY DET OF COXSACKIE A9 VIRUSK936073 · GNMChemicon Intl., Inc.510(k)Sep 8, 1995FDA decision date
COXSACKIE A24 VIRUS MONOCLONAL ANTIBODYK936089 · GNMChemicon Intl., Inc.510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B1 MONOCLONAL ANTIBODYK936145 · GNMChemicon Intl., Inc.510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B3 MONOCLONAL ANTIBODYK936251 · GNMLight Diagnostics510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B@ MONOCLONAL ANTIBODYK936252 · GNMLight Diagnostics510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B4 MONOCLONAL ANTIBODYK936253 · GNMLight Diagnostics510(k)Sep 8, 1995FDA decision date
COCKSACKIEVIRUS B6 MONOCLONAL ANTIBODYK936254 · GNMLight Diagnostics510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B BLEND MONOCLONAL ANTIBODIESK940471 · GNMChemicon Intl., Inc.510(k)Sep 8, 1995FDA decision date
COXSACKIEVIRUS B5 MONOCLONAL ANTIBODYK940472 · GNMChemicon Intl., Inc.510(k)Sep 8, 1995FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗